Sangamo Therapeutics

9 followers


For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases.

Industries

Employees

201-500

Links


Org chart

Collapse
Scott Willoughby
General Counsel & Corporate Secretary
Nathalie Dubois-Stringfellow
Senior Vice President, Product Development and Management
Stephanie J. Seiler
Head, Business Development & Alliance Management
Louise Wilkie
Global Corporate Communications & Investor Relations

Board & advisors

H. Stewart Parker
Chairwoman of the Board
James R. Meyers
President and Chief Executive Officer, IntraBio
Robert F. Carey
President and Chief Operating Officer, Acelyrin, Inc.